1. Home
  2. NCRA vs QTTB Comparison

NCRA vs QTTB Comparison

Compare NCRA & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCRA
  • QTTB
  • Stock Information
  • Founded
  • NCRA 2002
  • QTTB 2015
  • Country
  • NCRA Taiwan
  • QTTB United States
  • Employees
  • NCRA N/A
  • QTTB N/A
  • Industry
  • NCRA Farming/Seeds/Milling
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCRA Consumer Staples
  • QTTB Health Care
  • Exchange
  • NCRA Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • NCRA 16.8M
  • QTTB 19.0M
  • IPO Year
  • NCRA N/A
  • QTTB N/A
  • Fundamental
  • Price
  • NCRA $1.02
  • QTTB $1.90
  • Analyst Decision
  • NCRA
  • QTTB Hold
  • Analyst Count
  • NCRA 0
  • QTTB 8
  • Target Price
  • NCRA N/A
  • QTTB $24.00
  • AVG Volume (30 Days)
  • NCRA 132.9K
  • QTTB 108.9K
  • Earning Date
  • NCRA 05-15-2025
  • QTTB 05-08-2025
  • Dividend Yield
  • NCRA N/A
  • QTTB N/A
  • EPS Growth
  • NCRA N/A
  • QTTB N/A
  • EPS
  • NCRA N/A
  • QTTB N/A
  • Revenue
  • NCRA $16,647,379.00
  • QTTB N/A
  • Revenue This Year
  • NCRA N/A
  • QTTB N/A
  • Revenue Next Year
  • NCRA N/A
  • QTTB N/A
  • P/E Ratio
  • NCRA N/A
  • QTTB N/A
  • Revenue Growth
  • NCRA N/A
  • QTTB N/A
  • 52 Week Low
  • NCRA $0.70
  • QTTB $1.38
  • 52 Week High
  • NCRA $2.09
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • NCRA 50.34
  • QTTB 55.70
  • Support Level
  • NCRA $0.91
  • QTTB $1.56
  • Resistance Level
  • NCRA $1.25
  • QTTB $2.02
  • Average True Range (ATR)
  • NCRA 0.11
  • QTTB 0.15
  • MACD
  • NCRA -0.00
  • QTTB 0.03
  • Stochastic Oscillator
  • NCRA 22.29
  • QTTB 74.73

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: